![](/img/cover-not-exists.png)
A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer
Miguel Martin, Maria Blasinska-Morawiec, J. Fernando Salas, Silvia Falcon, Janusz Rolski, Bruno L. Ferrari, Stephen Gulyas, Yushan Liu, Karim A. BenhadjiVolume:
9
Year:
2009
Language:
english
DOI:
10.3816/cbc.2009.n.025
File:
PDF, 119 KB
english, 2009